CD8A and neoplasm: In our recent study, the presence of s.c. B16 melanoma tumor in addition to the intracranial tumor was required for efficient trafficking of CD8+ T cells to brain tumors following combined PD-1 plus CTLA-4 blockade (Taggart et al., 2018).